Will Clifton News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CobiCure Medical Technologies announced that it provided $2 million in funding to PolyVascular to advance a new heart valve for children.

It's down to the Final Five on the "The Voice." Among those competing is 14-year-old Hailey Mia from Clifton.

PolyVascular Awarded $2 Million Small Business Innovation Research Grant to Bring the First Polymer-Based Heart Valve for Children to Clinical Trials Ultimate goal is to help 1 million pediatric patients with congenital heart disease around the world with more dependable and affordable solution May 13, 2021 — PolyVascular, leading the effort to improve children's lives with a novel polymeric transcatheter valve (PTV) for children, announced that it was awarded a $2 million Small Business Innovation Research (SBIR) Phase II grant earlier this year to bring its polymeric stent-mounted valve...

PolyVascular awarded $2 Million SBIR grant The company is working to bring the first polymer-based heart valve for children to clinical trials. PolyVascular, leading the effort to improve children's lives with a novel polymeric transcatheter valve (PTV) for children, announced today that it was awarded a $2 million Small Business Innovation Research (SBIR) Phase II grant earlier this year to bring its polymeric stent-mounted valve (SMV) to clinical trials within the next two years in an effort to address pediatric congenital heart disease (CHD), which affects over 1 million patients around th...

April 1, 2021 By Bio-IT World Staff April 1, 2021 | New investment funds for late-stage companies and public health. Next-gen genomic medicines and single-cell multiomics get cash, and PatientsLikeMe raises a new round of funding to expand.   $969M Investment Fund for Early to Late-Stage Companies Foresite Capital, a multi-stage healthcare and life sciences investment firm, has announced its fifth and largest fundraise with $969 million in capital commitments, significantly oversubscribed above its original target. The offering comprises Foresite Capital Fund V, L.P. and Foresit...